Booth, Berit B.
Tranberg, Mette
Gustafson, Line W.
Christiansen, Anne G.
Lapirtis, Helle
Krogh, Lisa M.
Hjorth, Ina Marie D.
Hammer, Anne
Article History
Received: 26 October 2022
Accepted: 26 April 2023
First Online: 5 May 2023
Declarations
:
: As the study was classified as a quality assurance study according to Danish guidelines, the study was registered and approved on January 28, 2020 by the hospital administration in each of the four participating hospitals, as required by Danish legislation (no record number available). Only medical records of patients were used and the informed consent was waived by approval of each of the hospitals administrations in the participating hospitals. The approving hospitals are Randers Regional Hospital, Horsens Regional Hospital, Viborg Regional Hospital and Goedstrup Hospital. All methods were therefore carried out in accordance with relevant guidelines and regulations in Denmark.
: Not applicable.
: AH, LWG, and MT have received a speaker’s fee from Astra Zeneca and reagents for free from Roche, Denmark, outside the submitted work. The remaining authors declare no conflicts of interest.